Join BOPA
Back to news articles

Association for Supportive & Palliative Care Pharmacy (ASPCP) Annual Conference

By BOPA committee on 3rd October 2024

The Association for Supportive & Palliative Care Pharmacy (ASPCP) is a UK representative association for pharmacy professionals to improve the care of people affected by advanced life-limiting disease. Our annual conference brings together professionals from the field for a day of learning, networking, and fun. Join us for insightful talks, engaging workshops, and interactive sessions. Connect with like-minded individuals and expand your knowledge base. This is your opportunity to stay current with industry trends and best practices. Come and be part of this exciting event that promises to be both educational and enjoyable. Don’t miss out!

ASPCP Annual Conference 2024 Tickets, Thu 14 Nov 2024 at 08:45 | Eventbrite

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article